| Literature DB >> 32394891 |
Céline Dard1, Eve Tessier2, Duc Nguyen3, Loïc Epelboin4, Dorothée Harrois5, Christopher Swale6, André Cabié7, Katia de Meuron8, Charline Miossec2, Nicole Desbois-Nogard2.
Abstract
Neuroangiostrongyliasis is a parasitic disease caused by the accidental ingestion of the nematode Angiostrongylus cantonensis in its larval form. Human infection can lead to eosinophilic meningitis, sometimes complicated by life-threatening radiculomyelitis or encephalitis. Although some cases have been reported from other Caribbean Islands, no cases have been diagnosed in Martinique so far. Here, we report the first eight laboratory-confirmed cases of neuroangiostrongyliasis on the island of Martinique, French West Indies, between 1 January 2002 and 31 December 2017. One case was fatal and five resulted in neurological sequelae. The medical community should consider the risk of A. cantonensis infection in patients living in or returning from Martinique. © C. Dard et al., published by EDP Sciences, 2020.Entities:
Keywords: Angiostrongyliasis; Angiostrongylus cantonensis; Caribbean; Encephalitis; Eosinophilia; Helminth; Martinique; Meningitis
Mesh:
Substances:
Year: 2020 PMID: 32394891 PMCID: PMC7216674 DOI: 10.1051/parasite/2020032
Source DB: PubMed Journal: Parasite ISSN: 1252-607X Impact factor: 3.000
Description of the probable cases (numbers 1–4) and confirmed cases (numbers 5–8) of Angiostrongylus cantonensis infection in Martinique, including clinical, biological, imaging, and epidemiological features.
| Case | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
|---|---|---|---|---|---|---|---|---|
| Demographic characteristics | ||||||||
| Year | 2002 | 2002 | 2006 | 2008 | 2013 | 2015 | 2015 | 2015 |
| Season | Dry | Rainy | Rainy | Rainy | Rainy | Dry | Rainy | Rainy |
| Sex | F | M | F | M | M | M | M | M |
| Age | 10.5 months | 11 months | 13 months | 37 years | 64 years | 61 years | 58 years | 11.5 years |
| Residential locality | Fort-de-France | Le Lamentin | Cap Ferré, Saint-Anne | Le Diamant | ND | Fort-de-France | Quartier Morne Etoile, le Lorrain | Quartier Petit Versailles, Saint-Anne |
| Medical history | None | None | None | Substance addiction, bipolar | Intellectual disability | Diogenes syndrome | Schizophrenia | Autism, stunted growth |
| Risky behaviour | Playing on soil | Accidental slug ingestion | Unknown | Undercooked snail consumption | Stays in forest several days | Unknown | Pica disorder | Pica disorder |
| Clinical presentation | ||||||||
| Fever | Yes | Yes | Yes | No | Yes | No | No | Yes |
| Neurological signs and symptoms | Strabismus, cranial nerves VI palsy | Seizures | Hypotonia, tetraplegia | Radiculalgia, cranial nerves VI palsy | Headaches, coma | Headaches, Neck stiffness, cranial nerves VI palsy | Extrapyramidal syndrome, seizures, left hemiparesis, coma | Difficult examination because of autism |
| Digestive signs and symptoms | Anorexia | None | None | Nausea, vomiting | None | Loss of appetite | None | Loss of appetite, constipation |
| Others | ND | ND | ND | ND | ND | ND | ND | Itching |
| Laboratory tests | ||||||||
| CRP (mg/L) | <5 | <5 | <5 | 11.6 | 74 | <5 | <5 | <5 |
| Total WBC count (G/L) D0 | 8.24 | 15.09 | 10.03 | 10.00 | 12.20 | 16.35 | 6.61 | 20.75 |
| Eosinophils in blood G/L (%) D0/max value | 0.49 (5)/5.46 (32) | 2.23 (14)/3.23 (26) | 2.11 (21)/3.66 (17) | 0.62 (8)/0.89 (10) | 1.40 (11)/2.49 (21) | 1.77 (11)/2.76 (13) | 1.67 (25)/1.98 (36) | 6.43 (31)/6.43 (31) |
| WBC count in CSF 1st LP | 170 | 600 | 0 | 389 | 1040 | 410 | 2280 | 1080 |
| Eosinophils in CSF/mm3(%) 1st LP/max value | 59 (35)/355 (48) | 90 (15)/392 (49) | 0 (0)/220 (38) | 0 (0)/59 (62) | 600 (60)/600 (60) | 16 (4)/45 (18) | 1550 (68)/1550 (68) | 691 (64) |
| Proteinorachia g/L D0/max value | 1.25/1.25 | 0.52/0.85 | 0.33/0.83 | 1.17/1.17 | 1.10/1.10 | 1.71/1.71 | 1.50/3.70 | 0.63 |
| Glycorachia mmol/L D0/min value | 0.1/0.1 | 1.7/1.0 | 3.5/0.2 | 2.3/1.8 | 4.3/4.3 | 1.0/1.0 | 3.3/0.9 | 3.4 |
| Intracranial Hypertension | ND | ND | No | Yes, 37 | No | Yes | ND | ND |
| Angiostrongylus serodiagnosis | Positive | Negative | Negative | Negative | Positive D3, D19 | Positive | Positive | Positive |
| Positive | Positive | |||||||
| Cross-reactions (sera) | Cysticercosis (1/2048e) | None | None | |||||
| Specific antibodies in CSF | Positive | Positive | Positive | Positive | ND | ND | Positive | Positive |
| Parasitological examination of faeces | Negative | Negative | Negative | Negative | Negative | Negative | Negative | Negative |
| Brain CT-scan | Subnormal | None | None | ND | Normal | Normal | ND | Normal |
| Brain MRI | Ventricular dilatation | Normal | Hydrocephalus, ventricular dilatation, myelitis | Normal | Leukoaraiosis, cortico – subcortical atrophy | Normal | Ventricular dilatation | Abnormal(no precisions) |
| Management & outcome | ||||||||
| Treatment | Thiabendazole, albendazole | Albendazole | Albendazole, prednisone | Subtractive LP | Albendazole, prednisone | Albendazole + MPS | Albendazole + MPS | Albendazole + MPS |
| Subtractive LP | Subtractive LP | Subtractive LP | Subtractive LP | |||||
| Hospitalization time (days) | 55 | 15 | 34 | 19 | 49 | 66 + 90 days of physiotherapy | 20 | 16 |
| Clinical outcome, sequelae | Strabismus | Recovery | Psychomotor retardation | Strabismus | Recovery | Memory disorders, cranial nerves VI palsy | D20: death | Vision disorders |
Abbreviations: CSF, cerebrospinal fluid; CT-scan, computerised tomography scan; CRP, C-reactive protein; Dx, day x after admission to hospital; LP, lumbar puncture; MPS, methylprednisolone; ND, not determined.
Normal values: CRP: <5 mg/L; protein level in CSF: 0.15–0.40 g/L; glucose level in CSF: 2.8–4.5 mmol/L; intracranial tension: <20.
Serology performed by indirect immunofluorescence in the Medical Center of Gonesse, France.
Serology performed by western-blot analysis in the Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok, Thailand.
Serology performed by western-blot analysis in the Swiss Tropical and Public Health Institute, Basel, Switzerland.
Characteristics of the eight patients with eosinophilic meningitis caused by Angiostrongylus cantonensis.
| Characteristic | Result |
|---|---|
| Demographic characteristics | |
| Age (years) | 24.3 [0.87–63.6] |
| Sex (male) | 6 (75%) |
| Rainy season | 6 (75%) |
| Exposure risk | |
| Reported contact with snails | 2 (25%) |
| Previous mental disorders | 5 (63%) |
| Clinical picture | |
| Fever (>38 °C) | 5 (63%) |
| Digestive signs and symptoms | 3 (38%) |
| Neurological signs and symptoms | 8 (100%) |
| Headaches | 2 (25%) |
| Neck stiffness | 1 (13%) |
| Dysfunction of cranial nerves | 3 (38%) |
| Seizure | 2 (25%) |
| Axial hypotonia, hemiparesia | 2 (25%) |
| Radiculalgia | 1 (13%) |
| Coma | 2 (25%) |
| Brain imaging | |
| Normal | 3 (38%) |
| Enlargement of cerebral ventricles | 3 (38%) |
| Cortical atrophy | 1 (13%) |
| Laboratory results | |
| In blood | |
| C-reactive protein > 5 mg/L | 2 (25%) |
| Total WBC count (G/L) | 10.0 [6.61–20.75] |
| Blood eosinophilia at admission (G/L) | 1.72 [0.49–6.43] |
| Blood eosinophilia at admission (% of WBC) | 12.5 [5–31] |
| Max blood eosinophilia during hospitalisation (G/L) | 2.99 [0.89–6.43] |
| Max blood eosinophilia during hospitalisation (% of WBC) | 23.5 [10–36] |
| | 7 (88%) |
| In CSF | |
| Eosinophilia in CSF at first LP (/mm3) | 74.5 [0–1550] |
| Eosinophilia in CSF at first LP (% of WBC) | 25.0 [0–68] |
| CSF glucose at first LP (mmol/L) | 2.81 [0.1–4.3] |
| Protein level in CSF at first LP (g/L) | 1.14 [0.33–1.71] |
| Protein level > 0.45 g/L at first LP | 7 (88%) |
| Presence of antibodies in CSF (among those tested) | 6 (100%) |
| Management | |
| Length of hospital stay (days) | 27 [15–66] |
| Subtractive LP | 5 (63%) |
| Corticosteroids | 5 (63%) |
| Anthelmintic therapy | 7 (88%) |
| Outcome | |
| One year recovery | 2 (25%) |
| One year neurological sequelae | 5 (63%) |
| One year mortality | 1 (13%) |
Abbreviations: CSF, cerebrospinal fluid; LP, lumbar puncture; WBC, white blood cell.
Descriptive results are presented as n (%) and as median (min–max).